Back
CRISPR Therapeutics AG Stock Predictions

10 Stellar Stocks - get the names here
Learn their names here. FREE
Sell
38
CRSP
CRISPR Therapeutics AG
Last Price:
$47.89
Seasonality Move:
5.98%
7 Day Trial
ALL ACCESS PASS
$
7

BigBear.ai stock just exploded on AI and big data plays, surging to a $2B valuation.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.CRISPR Therapeutics AG Stock Forecast
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 36.3% based on the past 8 years of stock performance.
-
CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is CRISPR Therapeutics AG Stock Undervalued?The current CRISPR Therapeutics AG [CRSP] share price is $47.91. The Score for CRSP is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 36.3% based on the past 8 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
38
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
-
CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
90.62
52-Week Low:
36.52
Prediction Charts
Market Cap:
4.1B
Price in USD:
47.91
Volume:
2.7M
Beta:
2.01
Technical Analysis
SMA50:
42.72
SMA100:
45.63
SMA200:
49.49
52-Wk Change:
-41.86%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?Yes, CRISPR Therapeutics AG is a publicly traded company.
-
What is the CRISPR Therapeutics AG stock quote today?The CRISPR Therapeutics AG stock price is 47.91 USD today.
-
How to buy CRISPR Therapeutics AG stock online?You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Feb-3 | 40.19 | 40.00 | 41.10 | 39.21 |
Feb-4 | 40.00 | 40.49 | 41.11 | 39.75 |
Feb-5 | 40.79 | 42.22 | 42.60 | 40.53 |
Feb-6 | 42.71 | 40.61 | 42.88 | 40.54 |
Feb-7 | 41.00 | 39.71 | 41.74 | 39.35 |
Feb-10 | 40.00 | 39.41 | 40.04 | 39.18 |
Feb-11 | 39.01 | 39.62 | 39.72 | 38.28 |
Feb-12 | 40.67 | 43.30 | 44.20 | 40.50 |
Feb-13 | 43.70 | 43.49 | 44.14 | 42.20 |
Feb-14 | 46.21 | 49.72 | 52.60 | 46.04 |
Feb-18 | 52.25 | 52.22 | 55.30 | 51.02 |
Feb-19 | 52.40 | 53.02 | 55.88 | 52.23 |
Feb-20 | 52.58 | 50.43 | 52.77 | 49.22 |
Feb-21 | 51.23 | 47.91 | 51.47 | 47.34 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.15 per share, and an increase next year of $0.98 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.